Pharma Dodges The Tariff Bullet

President Donald Trump acted with restraint in his New Liberation Day tariffs, when he deferred imposing tariffs on pharmaceutical products from China, India and Europe. But, so long as these tariffs are being considered, their potential threat to the pharmaceutical industry and the people it serves remains.

These are difficult times for drug discovery and manufacturing. John Crowley the CEO of the Biotechnology…

Continue Reading


News Source: www.forbes.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *